Status epilepticus during the COVID-19 pandemic in Cologne, Germany: data from a retrospective, multicentre registry.

ABSTRACT:

Background

The "coronavirus disease 2019" (COVID-19) pandemic, caused by the "severe-acute-respiratory-syndrome-coronavirus 2" (SARS-CoV-2), challenges healthcare systems worldwide and impacts not only COVID-19 patients but also other emergencies. To date, data are scarce on the extent to which the COVID-19 pandemic impacted status epilepticus (SE) and its treatment.

Objective

To assess the influence of the COVID-19 pandemic on the incidence, management and outcome of SE patients.

Study design

This is a retrospective, multicentre trial, approved by the University of Cologne (21-1443-retro).

Methods

All SE patients from the urban area of Cologne transmitted to all acute neurological departments in Cologne between 03/2019 and 02/2021 were retrospectively analysed

SUBMITTER: Kohle F 

PROVIDER: S-EPMC9266085 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature